How we diagnose and treat WHO-defined systemic mastocytosis in adults
Authors:
- A. TefferiATA. Tefferi
- S. VerstovsekSVS. Verstovsek
- A. PardananiAPA. Pardanani
- 1 January 2008
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 93 (1) , 6-9
Abstract
Current classification and diagnosis of systemic mastocytosis, and its distinction from other myeloid malignancies associated with bone marrow mastocytosis, remain challenging for both clinicians and hematopathologists. In its upcoming revision, due out in 2008, the World Health Organization (WHO)Keywords
This publication has 46 references indexed in Scilit:
- Genetic and pharmacologic evidence implicating the p85α, but not p85β, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosisBlood, 2007
- Semaxinib (SU5416) as a therapeutic agent targeting oncogenic Kit mutants resistant to imatinib mesylateOncogene, 2006
- Imatinib mesylate responsiveness in aggressive systemic mastocytosis: Novel association with a platelet derived growth factor receptor beta mutationAmerican Journal of Hematology, 2006
- Allele-Specific Polymerase Chain Reaction for the Imatinib-Resistant KIT D816V and D816F Mutations in Mastocytosis and Acute Myelogenous LeukemiaThe Journal of Molecular Diagnostics, 2006
- Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosisClinical Rheumatology, 2006
- Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cellsBlood, 2006
- Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signatureJournal of Allergy and Clinical Immunology, 2005
- Long‐term follow‐up of indolent mastocytosis in adultsJournal of Internal Medicine, 1996
- Tryptase Levels as an Indicator of Mast-Cell Activation in Systemic Anaphylaxis and MastocytosisNew England Journal of Medicine, 1987
- Aggressive Topical Corticosteroid Therapy: A Novel Approach to Mast-Cell-Dependent Cutaneous DisordersDermatology, 1987